14, Aug 2026
NITI Aayog Identifies Four Sectors That Could Drive India’s Manufacturing Ambitions

New Delhi, August 14, 2026: NITI Aayog has identified chemicals, textiles, telecom and networking equipment, and solar photovoltaic (PV) manufacturing as four high-potential sectors that could play a central role in strengthening India’s position in global manufacturing.

The policy think tank’s report focuses on sectors where targeted policy interventions, stronger domestic capabilities and greater value addition can help Indian manufacturers compete more effectively in international markets. The broader exercise covers 12 priority sectors with the objective of increasing India’s participation in global value chains.

NITI Aayog has pointed to opportunities across the four sectors while also highlighting challenges such as import dependence, supply-chain gaps, cost competitiveness and skill shortages. Addressing these constraints will be critical for Indian companies to scale production and move higher up the global value chain.

The report comes as India seeks to raise the contribution of manufacturing to economic growth, exports and employment. NITI Aayog’s approach places greater emphasis on building competitive industrial clusters, improving infrastructure and reducing production costs to attract investment and expand exports.

The recommendations are expected to support India’s longer-term ambition of becoming a major global manufacturing centre by combining domestic demand with export-oriented production and deeper integration into international supply chains.

14, Aug 2026
Centre releasesRs.605.71 Crore to Strengthen Agriculture in Rajasthan and Telangana

New Delhi, August 14, 2026: The Centre has approved a combined allocation of ₹605.71 crore for Rajasthan and Telangana under the Pradhan Mantri Rashtriya Krishi Vikas Yojana (PM-RKVY) and the Krishonnati Yojana, aimed at supporting agricultural development and farmer-focused initiatives.

Rajasthan will receive ₹340.59 crore, while ₹265.12 crore has been approved for Telangana. The decisions followed a review of the states’ annual action plans, utilisation of earlier funds and expenditure progress.

Union Agriculture Minister Shivraj Singh Chouhan approved the allocations during a virtual meeting with Rajasthan Agriculture Minister Kirori Lal Meena and Telangana Agriculture Minister Tummala Nageswara Rao.

Chouhan also appreciated Telangana’s Farmer ID and fertiliser distribution model, highlighting its potential to make the delivery of agricultural services more transparent and efficient. For Rajasthan, he called for greater attention to the implementation of Kisan Credit Cards (KCC) to improve farmers’ access to institutional credit.

The latest funding is expected to support state-level agricultural programmes and strengthen efforts aimed at improving farm productivity, farmer services and rural livelihoods.

14, Aug 2026
SEBI Eyes Wider Accredited Investor Pool With ₹5 Crore Securities Threshold

Mumbai, August 14, 2026: The Securities and Exchange Board of India (SEBI) has proposed a new framework that could make it easier for financially sophisticated investors to qualify as accredited investors, with securities-market holdings emerging as an alternative eligibility criterion.

Under the proposal, an individual with ₹5 crore or more in securities assets could qualify for accredited investor status through this route. SEBI has also suggested a ₹20 crore securities-asset threshold for eligible body corporates and trusts, excluding family trusts.

The proposed changes are aimed at expanding the pool of investors who can participate in products and investment opportunities designed for accredited investors, including certain alternative investment structures. The regulator estimates that the new securities-assets route could potentially bring around 3.7 lakh additional investors into the eligible pool.

SEBI is also looking at making the accreditation process more streamlined. Under the proposed framework, investment managers could be permitted to assess and record an investor’s accredited status as part of the onboarding process.

The move reflects SEBI’s broader effort to make India’s investment ecosystem more accessible to investors with substantial market exposure, while maintaining eligibility standards based on financial capacity and sophistication. The proposals are subject to the regulatory consultation and final approval process.

14, Aug 2026
Rackspace Technology Appoints Chetan Gupta, Ph.D., as Chief AI Officer to Advance Enterprise and Sovereign AI

San Antonio, TX — Aug 14 — Rackspace Technology® (NASDAQ: RXT), a global enterprise AI infrastructure and solutions provider, today announced the appointment of Chetan Gupta, Ph.D., as Chief AI Officer. Gupta will lead the Office of AI, with responsibility for Rackspace’s AI strategy, research, innovation, governance, and adoption across the company and its customers. His appointment strengthens Rackspace’s ability to help institutions deploy AI safely, economically, and at scale in environments where the stakes are highest: regulated industries, sovereign jurisdictions, and mission-critical operations.

Gupta joins Rackspace after nearly a decade leading global AI research at Hitachi, where he served as General Manager of the Advanced AI Center in Japan, Vice President of the Industrial AI Lab in North America, and head of Hitachi’s Global AI Center of Excellence. His work was instrumental in Hitachi’s evolution toward Physical AI, building systems for railways, energy grids, factories, and buildings, environments where AI must operate under institutional accountability, jurisdictional requirements, and zero tolerance for failure. Earlier in his career, he spent seven years at HP Labs translating advanced AI research into deployed solutions across logistics, manufacturing, energy, and mobility. He has authored nearly 300 papers and patents and mentored a generation of AI researchers and engineers.

“Chetan has spent his career building AI for the institutions the world depends on. At Hitachi, that meant trains, grids, and factories, where AI is not a demo, but an operating commitment measured in uptime, safety, and trust,” said Gajen Kandiah, CEO of Rackspace Technology. “That is precisely the discipline our customers need as they move AI into production inside regulated and sovereign environments. Chetan understands that success depends on more than model capability. It requires strategy, governance, and an operator who carries accountability from silicon to outcomes.”

Gupta’s appointment reflects Rackspace’s continued investment in enabling institutions to turn AI ambition into governed, measurable business outcomes and reinforces the company’s position as the place where enterprise AI goes to production.

“AI has reached an inflection point. The hard problem is no longer capability. It is trust: taking promising research and turning it into systems that hold up in the real world, under real regulatory and operational constraints,” said Gupta. “Rackspace occupies a distinct position in the market, operating the full stack for institutions that cannot afford to get AI wrong. I look forward to leading our AI strategy and advancing enterprise and sovereign AI for our customers and across the business.”

Gupta holds a Ph.D. in mathematics and master’s degrees in mathematical computer science and chemical engineering from the University of Illinois Chicago.

 

14, Aug 2026
BIX 2026 to Spotlight the Future of Stem Cell and Global Biopharma M&A
 
SEOUL, South Korea | Aug 14— BIOPLUS-INTERPHEX KOREA 2026 (BIX 2026), Korea’s leading bio and pharmaceutical convention, hosted by Korea Biotechnology Industry Organization (KoreaBIO) and organized by RX, has announced this year’s conference keynote speakers and opened registration. 
 
BIX is a business platform that brings together companies, research institutions, and investors from Korea and abroad to explore collaboration opportunities. BIX 2026 will feature a range of programs, including a specialized conference covering the latest developments in biotechnology, market trends, and investment and business development strategies, as well as exhibitions, partnering programs, and business networking events. 
 
This year’s keynote sessions will focus on the future of research and treatment for nervous system diseases using stem cells and the current M&A trends in the global pharmaceutical and biotech industries, respectively. 
 
Temple, who will deliver the opening-day keynote on October 28, is Co-founder and Scientific Director of the Neural Stem Cell Institute (NSCI) and Co-founder and Chief Scientific Officer (CSO) of Luxa Biotechnology LLC. She is a world-renowned researcher in the fields of stem cells and neuroscience, having served as President of the International Society for Stem Cell Research (ISSCR) and been elected to the National Academy of Medicine. 
 
In her keynote, “Human Stem Cells: Transforming the Fight Against Nervous System Disease”, she will explore how human stem cell technologies are transforming the way nervous system diseases are studied and treated. The session will cover applications ranging from disease modeling and drug discovery to cell therapy, highlighting the translation of stem cell research into therapeutic development. 
 
On October 29, Stuart Cable, Global Head of Mergers & Acquisitions and Vice Chair at Goodwin, will take the stage as the second keynote speaker. Cable is a biopharmaceutical M&A expert who advises pharmaceutical and biotechnology companies on mergers and acquisitions, corporate governance, and capital markets. He has participated in numerous global biotech M&A transactions, including Sanofi’s acquisition of Blueprint Medicines, Merck’s acquisition of SpringWorks Therapeutics, and AstraZeneca’s acquisition of Fusion Pharmaceuticals. 
 
He will examine “Current Trends in Biopharma M&A”, the acquisition of innovative biotech companies by big pharma and mid-sized pharmaceutical companies. The session will cover key aspects of the current M&A landscape, including deal flow, deal size and structure, executive compensation, material adverse effects (MAE), public versus private targets, and regulatory considerations.  
 
In addition to these two keynote sessions, BIX 2026 will feature a variety of specialized sessions covering technological and market developments in the bioindustry. Industry leaders from biotech and pharmaceutical companies, research institutions, and investment firms will participate to share the latest R&D trends, strategies for global market entry, investment, technology commercialization, and business development. 
 
Pre-registration for BIX 2026 is open through August 31. Discounts on passes are available for those who register during the early-bird period. 
14, Aug 2026
Project Serotonin Unveils Ready-to-Deploy Preventive Healthcare Platform for Hospitals and Clinics

Bengaluru, Karnataka Aug 14: Project Serotonin (www.projectserotonin.com) announced the launch of its tenth-generation Preventive Health Platform and Precision Health OS, at the recently concluded RISE for Healthy Aging, the Longevity India Conference held at the Indian Institute of Science (IISc), Bengaluru. The Platform is designed to enable large hospitals, multispecialty hospitals, clinic networks, and longevity centers to deliver continuous, personalized preventive care by integrating fragmented health information into actionable precision interventions and measurable outcomes.

Preventive Health Platform & Precision Health OS

Project Serotonin’s Preventive Health Platform offers modular, ready-to-deploy infrastructure to operationalize preventive care at scale. It creates a connective layer that brings diagnostics, genomics, blood biomarkers, wearable data, clinical records, and practitioner insight into one model of care. It helps healthcare institutions move beyond isolated interventions toward a coordinated approach that supports individuals before disease progresses rather than after its onset.

The Platform has been designed to complement existing healthcare infrastructure, not compete with it. Hospitals and clinics continue to practice medicine through their established clinical pathways, while Project Serotonin adds a structured prevention layer supporting risk stratification, protocol design, patient engagement, monitoring, and behavior change, without asking clinicians to change how they practice or hospitals to trade treatment revenue for prevention.

The need for change has become increasingly evident. According to the World Health Organization, non-communicable diseases account for nearly 75 percent of all deaths globally. In India, where non-communicable diseases often present three to ten years earlier than in developed nations and multimorbidity has increased dramatically over the past three decades, a recent EY–FICCI assessment concluded that appropriate preventive interventions could reduce hospitalizations by 20 to 30 percent.

Advances in genomics, blood biomarkers, imaging, wearable technologies, and artificial intelligence have significantly expanded the volume and diversity of health information available to clinicians. Yet most healthcare institutions continue to use these datasets in isolation, limiting their ability to build a longitudinal understanding of an individual’s health and leaving preventive care fragmented and difficult to scale.

At the core of the Platform is Project Serotonin’s proprietary Precision Health OS, an orchestration engine that evaluates each individual’s genetic predispositions, biomarker trajectories, wearable trends, lifestyle patterns, pharmacogenetic considerations, and clinical history as one unified health profile. The Precision Health OS incorporates safeguards for contraindications, interactions, and escalation pathways, alongside anonymization, encryption, and role-based access controls.

This intelligence is translated into the SRTN Precision Daily Operating System (SRTN-pDOS), an individualized care framework that converts complex biological information into structured, practitioner-guided protocols across two care formats: foundational preventive care and therapy-adjunct protocols addressing specific health areas such as gut and cardiovascular health.

These SRTN precision protocols draw on an evidence base of more than 44,000 stratified clinical studies and have been refined through real-world pilots. They span nutrition, supplementation, physical activity, sleep, stress management, and other modifiable health behaviors. Recommendations are delivered through the SRTN App and supported by care concierge teams and health coaches who help individuals sustain adherence over time. WHO evidence has documented adherence rates as low as 28 percent for some regular preventive therapies in developed countries, underscoring the challenge of sustaining long-term engagement. Project Serotonin’s engagement architecture is designed to address this gap.

“We are at an inflection point in human health. Project Serotonin is built for the Medicine 4.0 era, which is defined not by how much data we collect, but by how intelligently we connect it,” said Dr Ashwat Visvanathan (PhD), Head – Partnerships and User Outcomes, Project Serotonin. “Healthcare has invested heavily in digitizing records and expanding diagnostics. The next frontier is enabling a continuous understanding of every individual. We built Project Serotonin to help healthcare providers move from episodic treatment to plug-and-play precision prevention, without disrupting the systems and clinical expertise they already have.”

The Platform connects twelve integrated systems that have traditionally functioned in isolation, from diagnostics, genomics, and wearable intelligence to a clinician console, Rx Intelligence screened against more than 2,600 drugs, patient engagement, fulfillment, adherence coaching, and operational management. Institutions can deploy the complete Platform or adopt modular capabilities, determining their own pace and scope of adoption.

14, Aug 2026
2026 International Congress of Basic Science Opens in Beijing

BEIJING, Aug. 14, 2026 /PRNewswire/ — The 2026 International Congress of Basic Science (ICBS 2026) opened on August 9 in Beijing, bringing together four Fields Medalists — Shing-Tung Yau, Maxim Kontsevich, Martin Hairer and Caucher Birkar — and Turing Award laureate Robert Tarjan, alongside Li Luming, president of Tsinghua University. More than 80 recipients of the Shaw Prize, Wolf Prize and Dirac Medal, some 400 internationally recognized scholars, and more than 800 researchers and students from over 30 countries and regions gathered for the flagship event.

On behalf of Tsinghua University, Li Luming welcomed the Chinese and international scientists attending the event and emphasized the important role that leading research universities should play in advancing basic research in the era of AI. In recent years, Tsinghua has deepened its commitment to fundamental disciplines by increasing investment, attracting world-class researchers, harnessing AI to accelerate scientific discovery, and enhancing its capacity for independent talent cultivation. Looking ahead, Tsinghua will strengthen its capacity for original innovation, cultivate future talent for basic research, and make greater contributions to expanding the frontiers of human knowledge and advancing human civilization.

In his remarks, ICBS President Yau noted that China has expanded its support for basic research through increased funding, policy initiatives, talent development and investments in research infrastructure. While AI can dramatically accelerate mathematical deduction and theorem proving, it does not replace the human capacity for creativity, intuition and the timeless pursuit of questions whose answers are not yet known. Major leaps in basic science always emerge at the intersection of disciplines and the willingness to venture into uncharted territory.

Two major honors were conferred during the ceremony: the ICBS Medal and the Frontiers of Science Award.

Nine scientists received the inaugural ICBS Medal for contributions spanning mathematics, physics and engineering: Claire Voisin, Horng-Tzer Yau, Shouwu Zhang, Andrea J. Liu, Yifang Wang, Xiao-gang Wen, Zhenan Bao, Xiaowei Zhuang and Feng Zhang. Four of this year’s medalists are women.

The Frontiers of Science Awards recognized 111 high-impact original research papers from more than 20 countries and regions. Nineteen of the recognized papers were authored by researchers from 17 Chinese institutions, including two papers featuring five scholars from Tsinghua University, spanning fields such as geometric analysis, quantum theory, large AI models, and computer vision.

Cision View original content:https://www.prnewswire.co.uk/news-releases/2026-international-congress-of-basic-science-opens-in-beijing-302851600.html

14, Aug 2026
VST Tillers Tractors Sustains Profitability as Revenue Climbs 11% Amid Cost Pressures

VST Tillers Tractors Limited reports 11% Revenue Growth with PAT Maintained at 14.27%, Despite Commodity Inflationary Pressures

 

Bengaluru, Aug 14: VST Tillers Tractors Limited (VST), India’s leading farm equipment manufacturer, announced its financial results for the 1st quarter of the financial yearshowcasing continued growth momentum and operational resilience.

 Financial Highlights – Q1 FY 2026-27

 Revenue from operations increased to ₹ 313.40 crore, registering a growth of 11% compared to 282.5 crore in Q1 FY26, amid supply disruptions.

 Operational EBITDA increased to 40.29 crore from 37.50 crore in the Q1 of previous year. Operational EBITDA margin is at 12.85% despite commodity inflationary pressures.

 Profit After Tax (PAT) stood at 48.73 crore as against 44.56 crore, an increase of 9.36% over Q1 FY 26.

VST Tillers Tractors Limited (VST) is India’s leading farm equipment manufacturer. VST was established in the year 1967 by the VST Group of companies. With a legacy of more than 55 years, VST continues to drive farm mechanization and empowerment of Indian farmers. The organization is the largest Indian manufacturer of Tillers, and 4WD Compact Tractors, and amongst the leading producers of the other category of Tractors, Engines, Transmission, Power Reaper, and Precision Components. VST also exports products to European, Asian, and African markets. 

14, Aug 2026
Rangi Developments – Building a Legacy Across the Tricity

Rangi Developments – Building a Legacy Across the Tricity

Projects and Services:
RANGI DEVELOPMENTS | RANGI GROUP | RANGI FINANCIALS | MEWS GATE | UBBER Group | HELPMATE | HELPMATE SERVICES | HIGHLAND PARK | HIGHLAND MAYFIELDS | HIGHLAND LIFESPACES | HIGHLAND INDUSTRIAL CITY | HIGHLAND LUXURIA | CRESTA |CRESTA RESIDENCES

Rangi, through Rangi Developments, has built an established presence in the real estate sector across the Tricity and surrounding region. With delivered projects including Mews Gate, Highland Park and Ubber Parkland, Rangi has created residential and commercial spaces that are now home to numerous families, communities and businesses. The journey is supported by the wider Rangi Group and its associated names, including Highland Group, Highland Mayfields and Highland Lifespaces, reflecting years of experience across the real estate sector.

Among its notable developments, Mews Gate is an integrated residential and commercial destination bringing together thoughtfully planned homes and commercial spaces. Highland Park, Highland Mayfields, Highland Lifespaces and Highland Luxuria further represent the group’s experience across residential development, with established communities now living and growing within these projects.

Building on this experience, Rangi Developments is preparing to introduce Cresta, also known as Cresta Residences, an upcoming residential development envisioned around contemporary architecture, thoughtfully planned spaces and modern lifestyle requirements.

With a portfolio shaped by delivered developments and established communities, Arshdeep Rangi is taking the lead in carrying this legacy forward through the upcoming Cresta Residences, building on the experience of the past while shaping the vision for the future.

14, Aug 2026
Elliott Management Statement on Northern Star Resources Ltd

WEST PALM BEACH, Fla., Aug. 13, 2026 /PRNewswire/ — Elliott Investment Management L.P. (“Elliott”), which manages funds that together hold an investment of approximately 5.6% in Northern Star Resources Ltd (“Northern Star” or the “Company”), today issued the following statement in response to the Company’s announcements on August 13:

Elliot logo

Northern Star’s August 13 letter asks investors to trust the very directors who presided over years of profound underperformance to oversee a Board “renewal” process on terms they alone control, consisting of directors appointed solely at their discretion. This is not renewal. It is entrenchment.

Elliott remains willing to work constructively with Northern Star toward a genuinely strengthened Board equipped to realize the Company’s full potential – for investors, employees and all who depend on its success.

Elliott’s full perspectives on Northern Star and its unique value-creation opportunity can be accessed at ElliottLetters.com/NST.

About Elliott

Elliott Investment Management L.P. (together with its affiliates, “Elliott”) manages approximately $80.3 billion of assets as of June 30, 2026. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm.

Media Contacts:

London

Stijn van de Grampel

Elliott Advisors (UK) Limited

T: +44 20 3009 1061

svdgrampel@elliottadvisors.co.uk

New York

Stephen Spruiell

Elliott Investment Management L.P.

T: +1 (212) 478-2017

sspruiell@elliottmgmt.com

Sydney

Annabel Clunies-Ross

Hanbury Strategy

T: +61 428 295 517

nst@hanburystrategy.com

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/elliott-management-statement-on-northern-star-resources-ltd-302851456.html